http://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Podcast Hero Banner3gk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Online Program Plannergk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/AAAS Fellows Bannergk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Read New JMBE Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
19-01-2017mSphere Direct
19-01-2017Podcast banner
19-01-2017AAAS Fellows
19-01-2017Read new JMBE
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreats Meeting
REGISTER

liu junDr. Liu's work lies in the interdisciplinary area of chemical biology. His lab has elucidated the molecular mechanism of action of number of bioactive natural products of microbial origin. He and others discovered the type 2 methionine aminopeptidase as the target of the anti-angiogenic natural products fumagillin and ovalicin. His group also discovered that antitumor natural product lactimidomycin binds to the larger subunit of ribosome, blocking the elongation step of eukaryotic translation similar to cycloheximide. His lab has also identified, through high-throughput screening, a number of inhibitors of the methionine aminopeptidase family of enzymes that showed promising antimalarial and anti-mycobacterial activities.

 

Link to Group Website: http://www.hopkinsmedicine.org/pharmacology/research/liu.html

TPL_asm2013_SEARCH

91119